Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

ClinicalTrials.gov ID: NCT04072380

Public ClinicalTrials.gov record NCT04072380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy

Study identification

NCT ID
NCT04072380
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Suven Life Sciences Limited
Industry
Enrollment
190 participants

Conditions and interventions

Conditions

Interventions

  • SUVN-G3031 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 20, 2019
Primary completion
Jun 6, 2023
Completion
Jun 12, 2023
Last update posted
Jan 12, 2025

2019 – 2023

United States locations

U.S. sites
39
U.S. states
13
U.S. cities
33
Facility City State ZIP Site status
Sleep Disorders Center o f Alabama Birmingham Alabama 35213
Santa Monica Clinical Trials Los Angeles California 90025
Southern California Institute for Respiratory Diseases, Inc. Los Angeles California 90048-6138
Pacific Research Network, Inc. San Diego California 92103
SDS Clinical Trials Inc. Santa Ana California 92705
Meris Clinical Research Brandon Florida 33511
Teradan Clinical Trials Brandon Florida 33511
St. Francis Medical Institute Clearwater Florida 33765
PDS Research Kissimmee Florida 34741
Sleep Medicine Specialists of South Florida, PA Miami Florida 33126
Ivetmar Medical Group, LLC Miami Florida 33155
Florida Pediatric Research Institute Winter Park Florida 32789
Florida Pulmonary Research Institute, LLC Winter Park Florida 32789
NeuroTrials Research Inc Atlanta Georgia 30342
The Neuro Center Gainesville Georgia 30501
IACT Health Lawrenceville Georgia 30045
Sleep Practitioners, LLC Macon Georgia 31210
IACT Health Rincon Georgia 31326
Clinical Research Institute Stockbridge Georgia 30281
Helene A. Emsellem, MD PC Chevy Chase Maryland 20815
Bronson Sleep Health Portage Michigan 49024
Clinical Neurophysiology Services Sterling Heights Michigan 48314
St Lukes Hospital, Sleep Medicine & Research Center Chesterfield Missouri 63017
Clayton Sleep Institute St Louis Missouri 63123
Research Carolina Elite Denver North Carolina 28078
Clinical Research of Gastonia Gastonia North Carolina 28054
Ohio Sleep Medicine Institute Canton Ohio 44718
CTI Clinical Research Center Cincinnati Ohio 45212
Intrepid Research, LLC Cincinnati Ohio 45245
Cleveland Clinic, Sleep Disorders Center Cleveland Ohio 44195
Ohio Sleep Medicine Institute Dublin Ohio 43017
Respiratory Specialists Wyomissing Pennsylvania 19610
Medical University of South Carolina Charleston South Carolina 29425
Bogan Sleep Consultants Columbia South Carolina 29201
Lowcountry Lung Critical Care North Charleston South Carolina 29406
FutureSearch Trials of Neurology Austin Texas 78731
Sleep Therapy & Research Center San Antonio Texas 78229
Roadrunner Research San Antonio Texas 78249
Children's Hospital of the King's Daughters Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04072380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04072380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →